Cambridge-based BioTech company Mestag Therapeutics has been awarded a £1.5 million Transforming Cancer Therapeutics grant. The money comes from Innovate UK’s Cancer Therapeutics program to accelerate the development of its MST-0300 antibody. Innovate UK, part of UK Research and Innovation, is investing a total of £12m in innovation projects to advance next-generation immunotherapies for cancer. … Continue reading Mestag awarded £1.5m grant to revolutionise cancer treatment